Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
NCT07762131
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospital, Zhejiang University, School of MedicineNot Yet Recruiting
NCT07762131Not Yet Recruiting
—
AI-Based Precision Transfusion Prediction Model in Critically Ill PatientsSecond Affiliated Hospita...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07762352
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude do AlcoitaoCompletedNot Applicable
NCT07762352Completed
Not Applicable
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude...
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07764302
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Probenecid in Bone and Joint InfectionsAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07764302Not Yet Recruiting
Phase 3
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Prob...Assistance Publique - Hôp...
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07763379
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKAGE FOLLOWING PRIMARY REPAIR IN GASTROINTESTINAL SURGERYSohag UniversityRecruiting
NCT07763379Recruiting
—
THE ROLE OF C-REACTIVE PROTEIN (CRP) IN THE EARLY DIAGNOSIS OF ANASTOMOTIC LEAKA...Sohag University
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07763457
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduate School of MedicineNot Yet Recruiting
NCT07763457Not Yet Recruiting
—
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduat...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07762781
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy AdultsTokat Gaziosmanpasa UniversityCompletedNot Applicable
NCT07762781Completed
Not Applicable
Impact of a Mobile Exercise Application on Sleep, Pain, and Fitness in Healthy A...Tokat Gaziosmanpasa Unive...
NCT07763717
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIALAlma Mater Europaea - SloveniaNot Yet RecruitingNot Applicable
NCT07763717Not Yet Recruiting
Not Applicable
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE...Alma Mater Europaea - Slo...
NCT07764263
Contextualizing Care for Patients With a Serious IllnessRadboud University Medical CenterCompletedNot Applicable
NCT07764263Completed
Not Applicable
Contextualizing Care for Patients With a Serious IllnessRadboud University Medica...
NCT07764159
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of WarsawNot Yet RecruitingNot Applicable
NCT07764159Not Yet Recruiting
Not Applicable
Multi-Food Oral Immunotherapy for Peanut and Tree NutsMedical University of War...
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Active, not recruiting2 (10%)
Recruiting2 (10%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 41 (5%)
Phase 31 (5%)
Phase 21 (5%)